PH17398A - 1,5-disubstituted-2-pyrrolidones - Google Patents

1,5-disubstituted-2-pyrrolidones

Info

Publication number
PH17398A
PH17398A PH20060A PH20060A PH17398A PH 17398 A PH17398 A PH 17398A PH 20060 A PH20060 A PH 20060A PH 20060 A PH20060 A PH 20060A PH 17398 A PH17398 A PH 17398A
Authority
PH
Philippines
Prior art keywords
pyrrolidones
disubstituted
Prior art date
Application number
PH20060A
Other languages
English (en)
Inventor
Albin James Nelson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH17398A publication Critical patent/PH17398A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH20060A 1976-08-06 1977-08-02 1,5-disubstituted-2-pyrrolidones PH17398A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
PH17398A true PH17398A (en) 1984-08-08

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
PH20060A PH17398A (en) 1976-08-06 1977-08-02 1,5-disubstituted-2-pyrrolidones

Country Status (31)

Country Link
JP (2) JPS5321159A (cs)
AR (1) AR217080A1 (cs)
AT (1) AT362887B (cs)
AU (1) AU508007B2 (cs)
BE (1) BE857506A (cs)
BG (1) BG31073A3 (cs)
CA (1) CA1077948A (cs)
CH (1) CH624934A5 (cs)
CS (1) CS221269B2 (cs)
DD (2) DD136135A5 (cs)
DE (1) DE2735904A1 (cs)
DK (1) DK352077A (cs)
ES (2) ES461388A1 (cs)
FI (1) FI70009C (cs)
FR (1) FR2369260A1 (cs)
GB (2) GB1556569A (cs)
GR (1) GR68688B (cs)
HU (1) HU180273B (cs)
IE (1) IE45505B1 (cs)
IL (1) IL52615A (cs)
LU (1) LU77936A1 (cs)
NL (1) NL7708637A (cs)
NO (1) NO772752L (cs)
NZ (1) NZ184806A (cs)
PH (1) PH17398A (cs)
PL (2) PL200124A1 (cs)
PT (1) PT66891B (cs)
SE (1) SE423813B (cs)
SU (3) SU703016A3 (cs)
YU (1) YU192577A (cs)
ZA (1) ZA774704B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
ES2263557T3 (es) 2000-01-31 2006-12-16 Pfizer Products Inc. Uso de agonistas selectivos del receptor 4(ep4) de prostablandinas (pge2) para el tratamiento de insuficiencia renal aguda y cronica.
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
EA200300379A1 (ru) * 2000-11-27 2003-08-28 Пфайзер Продактс Инк. Селективные агонисты рецептора ep4 в лечении остеопороза
JP4273407B2 (ja) * 2001-07-23 2009-06-03 小野薬品工業株式会社 Ｅｐ４アゴニストを有効成分とする骨量低下疾患の治療剤
MXPA04005555A (es) * 2002-03-18 2005-05-16 Pfizer Prod Inc Procedimientos de tratamiento con agonistas selectivos del receptor ep4.
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
EP1586564B1 (en) * 2003-01-21 2012-11-28 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medicinal uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DD136135A5 (de) 1979-06-20
YU192577A (en) 1983-04-30
SE7708642L (sv) 1978-02-07
NL7708637A (nl) 1978-02-08
DE2735904A1 (de) 1978-02-09
FI70009C (fi) 1986-09-12
FR2369260B1 (cs) 1982-02-12
FI772376A7 (cs) 1978-02-07
PT66891A (en) 1977-09-01
ES471349A1 (es) 1979-09-16
PL200124A1 (pl) 1978-05-22
GB1556570A (en) 1979-11-28
BG31073A3 (bg) 1981-10-15
SE423813B (sv) 1982-06-07
NO772752L (no) 1978-02-07
JPS5321159A (en) 1978-02-27
BE857506A (fr) 1978-02-06
IL52615A0 (en) 1977-10-31
JPS5555161A (en) 1980-04-22
NZ184806A (en) 1980-04-28
AU2751577A (en) 1979-02-08
SU818480A3 (ru) 1981-03-30
IE45505B1 (en) 1982-09-08
CS221269B2 (en) 1983-04-29
FR2369260A1 (fr) 1978-05-26
ATA579477A (de) 1980-11-15
DD143768A5 (de) 1980-09-10
DK352077A (da) 1978-02-07
JPS585196B2 (ja) 1983-01-29
SU850000A3 (ru) 1981-07-23
CH624934A5 (cs) 1981-08-31
HU180273B (en) 1983-02-28
AU508007B2 (en) 1980-03-06
PL112931B1 (en) 1980-11-29
LU77936A1 (cs) 1978-04-27
GR68688B (cs) 1982-02-01
JPS5531147B2 (cs) 1980-08-15
ZA774704B (en) 1978-06-28
AT362887B (de) 1981-06-25
ES461388A1 (es) 1978-12-01
SU703016A3 (ru) 1979-12-05
PT66891B (en) 1979-01-26
AR217080A1 (es) 1980-02-29
CA1077948A (en) 1980-05-20
FI70009B (fi) 1986-01-31
IE45505L (en) 1978-02-06
IL52615A (en) 1981-09-13
GB1556569A (en) 1979-11-28

Similar Documents

Publication Publication Date Title
PH13932A (en) 1,2,3,4-tetrahydro-napthalenes
CY1155A (en) 2-piperazinyl-6,7-dimethoxyquinazolines
GB1524917A (en) Gona-1,9(10)-dienes
NZ183143A (en) 2-aminoakyl-1,2-benzisothiazol 3-anes
GB1542361A (en) 1,4-benzo-dioxan derivatives
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
PH17398A (en) 1,5-disubstituted-2-pyrrolidones
ZA773958B (en) 2,6-methano-2h-1-benzoxocins
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
AU2468877A (en) 1,4 -dicyanobytene
ZA774515B (en) O-ethyl-s-n-propyl-o-2,2,2-trihaloethylphosphorothiolates(or thionothiolates)
GB1537635A (en) 15,16-dihydroxyprostaglandins
HK36785A (en) 1-amino-alkyl-3,4-diphenyl-1h-pyrazoles
GB1538368A (en) 1,3,4,6-tetrathia and tetraselena-2,5-dihetero-pentalene compounds
GB1544339A (en) 2,3-dihydro-2-oxo-3-benzo(b)thiophenecarboxamides
GB1554049A (en) 2-decarboxy-2-hydroxymethyl-13,14-didehydroprostaglandins
NZ184082A (en) 1-benzothiazol-2yl-1,3-imidazolidin-2-ones
GB1547729A (en) 1-phenyl-4-acetoxy-1,2-dihydroquinolin-2-ones
IL53527A (en) N1-chloro-3,5-dinitrosulfanilamides
AU3191777A (en) 1,4-oxathianes
AU3178777A (en) Substituted 4,5-dihydroxy-imidazolidine-2-thiones
GB1546347A (en) 5,11-diazatetracyclo-(6.2.2.02,7 04,9)-dodecanes
GB1554045A (en) 13,14-didehydroprostaglandins
ZA774088B (en) 2,5-dichloro-4-bromphenylazo-4-chloro-phenyl-sulphide
PL187575A1 (en) Sposob otrzymywania pochodnych 3,4-dwuhydro-2h-1,3-benzoksazynotionu